GO Term | Evidence Code | PMID |
---|---|---|
T cell activation | ||
positive regulation of MAP kinase activity | ||
dendritic cell chemotaxis | ||
positive regulation of cytokine production | ||
natural killer cell chemotaxis |
GO Term | Evidence Code | PMID |
---|---|---|
1-phosphatidylinositol-4-phosphate 3-kinase activity | ||
ATP binding | ||
protein serine/threonine kinase activity |
|
|
kinase activity | ||
1-phosphatidylinositol-4,5-bisphosphate 3-kinase activity |
HPO ID | HPO Term |
---|---|
HP:0002720 | Decreased circulating IgA level |
HP:0002850 | Decreased circulating total IgM |
HP:0002851 | Elevated proportion of CD4-negative, CD8-negative, alpha-beta regulatory T cells |
HP:0003281 | Increased circulating ferritin concentration |
HP:0003621 | Juvenile onset |
HP:0003651 | Foam cells |
HP:0004313 | Decreased circulating antibody level |
HP:0004315 | Decreased circulating IgG level |
HP:0004387 | Enterocolitis |
HP:0005415 | Decreased proportion of CD8-positive T cells |
Disease ID | Disease Name |
---|---|
OMIM:619802 |
|
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
This work is licensed under Creative Commons Attribution 4.0 International
GlyCosmos Portal v4.1.1
Last updated: February 17, 2025